Ligand validation:3RGN

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 3RGN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3RGN_C8E_A_804	55%	71%	0.131	0.899	0.42	0.69	-	-	0	0	100%	1
3RGN_C8E_A_802	19%	58%	0.326	0.927	0.56	1.01	-	1	0	0	100%	1
3RGN_C8E_A_800	12%	74%	0.236	0.77	0.33	0.66	-	-	0	0	100%	1
3RGN_C8E_A_801	8%	65%	0.276	0.755	0.48	0.83	-	-	1	0	100%	1
3RGN_C8E_A_805	2%	62%	0.391	0.65	0.62	0.82	-	1	1	0	100%	1
3RGN_C8E_A_803	1%	75%	0.476	0.565	0.45	0.51	-	-	1	0	100%	1
3RGN_C8E_A_806	0%	72%	0.423	0.416	0.53	0.54	-	-	1	0	100%	1
1NQH_C8E_A_800	53%	61%	0.173	0.935	0.5	0.98	-	-	4	0	100%	1
3M8D_C8E_A_702	44%	63%	0.172	0.901	0.59	0.79	-	-	0	0	100%	1
1NQG_C8E_A_800	44%	47%	0.187	0.914	0.52	1.52	-	4	10	0	100%	1
3M8B_C8E_A_601	43%	71%	0.189	0.913	0.38	0.72	-	-	0	0	100%	1
1NQE_C8E_A_802	42%	70%	0.2	0.921	0.39	0.73	-	-	0	0	100%	1
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	0	100%	1
6EHD_C8E_A_409	64%	60%	0.105	0.903	0.41	1.08	-	2	3	0	100%	1
5MDO_C8E_B_404	61%	73%	0.118	0.908	0.36	0.65	-	-	0	0	100%	1
5DL7_C8E_A_506	61%	47%	0.123	0.912	0.72	1.34	-	3	4	0	100%	1
6HCP_C8E_C_824	59%	77%	0.116	0.924	0.46	0.46	-	-	1	0	86%	0.8571

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.